 Connection
John Messenger to Acute Coronary Syndrome
This is a "connection" page, showing publications John Messenger has written about Acute Coronary Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.073 |
|
|
|
-
Boulos PK, Messenger JC, Waldo SW. Readmission After ACS: Burden, Epidemiology, and Mitigation. Curr Cardiol Rep. 2022 07; 24(7):807-815.
Score: 0.165
-
Amin AP, Spertus JA, Kulkarni H, McNeely C, Rao SV, Pinto D, House JA, Messenger JC, Bach RG, Goyal A, Shroff A, Pancholy S, Bradley SM, Gluckman TJ, Maddox TM, Wasfy JH, Masoudi FA. Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary Intervention. Am J Cardiol. 2020 02 01; 125(3):354-361.
Score: 0.139
-
Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC, Moore JWM, Moussa I, Oetgen WJ, Varosy PD, Vincent RN, Wei J, Curtis JP, Roe MT, Spertus JA. Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data?Registries. J Am Coll Cardiol. 2017 Mar 21; 69(11):1427-1450.
Score: 0.114
-
Fosb?l EL, Ju C, Anstrom KJ, Zettler ME, Messenger JC, Waksman R, Effron MB, Baker BA, Cohen DJ, Peterson ED, Wang TY. Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome). Circ Cardiovasc Interv. 2016 11; 9(11).
Score: 0.113
-
Jackson LR, Peterson ED, McCoy LA, Ju C, Zettler M, Baker BA, Messenger JC, Faries DE, Effron MB, Cohen DJ, Wang TY. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. J Am Heart Assoc. 2016 10 21; 5(10).
Score: 0.112
-
Hess CN, Wang TY, McCoy LA, Messenger JC, Effron MB, Zettler ME, Henry TD, Peterson ED, Fonarow GC. Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. Circulation. 2016 Feb 02; 133(5):493-501.
Score: 0.106
-
Wang TY, McCoy LA, Messenger JC, Neely ML, Ho KK, Roe MT, Anderson HV. Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry. Am Heart J. 2013 Nov; 166(5):927-34.
Score: 0.091
-
Ellestad MH, Messenger J, Montgomery B, Nudell N, Narula J. Intracardiac electrogram and ischemia alert. J Am Coll Cardiol. 2012 Feb 07; 59(6):631-3.
Score: 0.081
-
Chin CT, Wang TY, Anstrom KJ, Zhu B, Maa JF, Messenger JC, Ryan KA, Davidson-Ray L, Zettler M, Effron MB, Mark DB, Peterson ED. Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. Am Heart J. 2011 Nov; 162(5):844-51.
Score: 0.080
-
Amin AP, Marso SP, Rao SV, Messenger J, Chan PS, House J, Kennedy K, Robertus K, Cohen DJ, Mahoney EM. Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding. Circ Cardiovasc Qual Outcomes. 2010 Jul; 3(4):358-65.
Score: 0.072
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|